Tris Pharma
develops and commercializes OTC, Rx and specialty generic medicines... Read moreTris Pharma
develops and commercializes OTC, Rx and specialty generic medicines... Read more
News
Jun 10, 2026
GlobalNewswire
Press Release: Tris Pharma : Tris Pharma Announces FDA Grant of Orphan Drug Designation for TRN-257 (Oxybate for Extended-Release Oral Suspension) a Once-Nightly, Low-Sodium Oxybate Product for Idiopathic Hypersomnia
Jun 08, 2026
GlobalNewswire
Press Release: Tris Pharma : Tris Pharma Introduces a New 60 mL Bottle Size for DYANAVEL XR (amphetamine) Extended-Release Oral Suspension CII
Jun 02, 2026
Benzinga
Tris Pharma: Tris Pharma Announces Presentation on The Complexity and Management of ADHD at Psych Congress Elevate 2026
May 05, 2026
GlobalNewswire
Press Release: Tris Pharma : STACK Infrastructure Appoints Bobby Hollis as Chief Development Officer
Apr 08, 2026
Benzinga
Tris Pharma: Tris Pharma to Showcase Encore Phase 3 Data Supporting Continued Progress in Acute Pain Treatment at ASRA 2026 Meeting in Phoenix
Feb 26, 2026
Benzinga
Tris Pharma: Tris Pharma to Present Debut Data from Phase 3 ALLEVIATE 1-2 Trials Evaluating Cebranopadol in Acute Pain at AAPM PainConnect 2026 Annual Meeting
Jan 08, 2026
StreetInsider
Press Release: Tris Pharma : Tris Pharma Announces Acceptance of New Publication Highlighting Promise of Dual NOP-MOP (dual-NMR) Agonists for the Treatment of Moderate-to-Severe Pain
Nov 20, 2025
Pharmaceutical Business Review
Tris Pharma: Pfizer and Tris reach settlement with Texas over ADHD drug allegations
Nov 20, 2025
EIN Presswire
Press Release: Tris Pharma : Brown, LLC Helps Secure $41.5 Million Texas False Claims Act Whistleblower Medicaid Settlement
Aug 06, 2025
PR Newswire
Press Release: Tris Pharma : Pulse Health partners with Tris Pharma to Power Omnichannel HCP Engagement for ADHD Products
Tris Pharma Competitors
1
2
3
4
5
6
7
8
9
10